Inogen (INGN) Capital Expenditures Growth (3y) (2016 - 2026)
Inogen (INGN) Capital Expenditures Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.13 Bn | 175.83 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 108.98 Bn | 99.76 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 48.01 Bn | 44.34 Bn | 1.29 Bn | 1.81% |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn | 7.57% |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn | 0.84% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 2.15% |
| 10 | Inogen | 173.36 Mn | 63.19 Mn | 37.86 Mn | -214.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -214.57% |
| Dec 31, 2025 | -178.19% |
| Sep 30, 2025 | 55.71% |
| Jun 30, 2025 | -57.24% |
| Mar 31, 2025 | -40.21% |
| Dec 31, 2024 | -87.64% |
| Sep 30, 2024 | 60.92% |
| Jun 30, 2024 | 265.10% |
| Mar 31, 2024 | 64.35% |
| Dec 31, 2023 | 49.72% |
| Sep 30, 2023 | 38.41% |
| Jun 30, 2023 | -26.32% |
| Mar 31, 2023 | 53.25% |
| Dec 31, 2022 | -26.90% |
| Sep 30, 2022 | -6.64% |
| Jun 30, 2022 | -5.78% |
| Mar 31, 2022 | 13.55% |
| Dec 31, 2021 | -27.27% |
| Sep 30, 2021 | 28.38% |
| Jun 30, 2021 | -26.22% |